Progress in Neuro-Psychopharmacology and Biological Psychiatry
October 3, 2016
Yong‐Ku Kim, Kyoung-Sae Na
Treatment-resistant depression (TRD) causes substantial socioeconomic burden. Although a consensus on the definition of TRD has not yet been reached, it is certain that classic monoaminergic antidepressants are ineffective for TRD. One decade ago, many researchers found ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist, to be an alternative to classic monoaminergic antidepressants....
Supportive Care in Cancer
October 2016
Patricia A Poulin, Heather Romanow, Noriyeh Rahbari et al.
This study aims to examine if mindfulness is associated with pain catastrophizing, depression, disability, and health-related quality of life (HRQOL) in cancer survivors with chronic neuropathic pain (CNP). We conducted a cross-sectional survey with cancer survivors experiencing CNP. Participants (n = 76) were men (24 %) and women (76 %) with an average age of 56.5 years (SD = 9.4)....
Australian & New Zealand Journal of Psychiatry
October 2016
Frances Shawyer, Joanne Enticott, Mehmet Özmen et al.
While mindfulness-based cognitive therapy is effective in reducing depressive relapse/recurrence, relatively little is known about its health economic properties. We describe the health economic properties of mindfulness-based cognitive therapy in relation to its impact on depressive relapse/recurrence over 2 years of follow-up. Non-depressed adults with a history of three or more major...
Scandinavian Journal of Psychology
October 2016
Josefine L Lilja, Clara Zelleroth, Ulf Axberg et al.
This study examined the effectiveness of mindfulness-based cognitive therapy (MBCT) in primary care for patients with recurrent depression (major depressive disorder: MDD). According to the World Health Organization (WHO), MDD is now the leading cause of disease burden in middle- and high-income countries. Patients (N = 45) with three or more previous depressive episodes were recruited to...
Medicinski pregled
October 2016
Dušan Kolar, Michael V Kolar
Treatment-resistant mood and anxiety disorders require an intensive therapeutic approach, and it should balance benefits and adverse effects or other potential detrimental effects of medications. The goal of treatment is to provide consistent and lasting improvement in symptoms of depression and anxiety. Beozodiazepines are effective for anxiety symptoms, but with no sustained treatment...
Schizophrenia Research
October 2016
Vina M Goghari, Martin Harrow
Hallucinations are a salient feature of both psychotic and mood disorders. Currently there is a call for more research on the phenomenology of different forms of hallucinations, in a broader array of disorders, to further both theoretical knowledge and clinical utility. We investigated auditory, visual, and olfactory hallucinations at index hospitalization and auditory and visual hallucinations...
Psychiatria i Psychologia Kliniczna
September 30, 2016
Karolina Dydak, Mariola Śliwińska‐mossoń, Halina Milnerowicz
2 citations
Psylocybina jest substancją psychodysleptyczną pochodzenia naturalnego, występuje w grzybach rodzaju Psilocybe. Psychodysleptyki są środkami psychoaktywnymi, które silnie wpływają na percepcję, nastrój i procesy poznawcze człowieka. Psychodeliczne działanie psylocybiny opiera się na pobudzaniu receptorów serotoninergicznych, co prowadzi do wzrostu stężenia serotoniny w mózgu oraz przyczynia się...
International Journal of Indian Psychology
September 25, 2016
Depression is the common cold of mental disorders. It is one of the main issues that needs to receive a great deal of attention in order to create grounds to be prevented or cured. It is interesting to note that there is extensive literature emphasising the role and effectiveness of CBT as the treatment of depression. But few researchers talk about combined effect of CBT and Mindfulness. So to...
Complementary Therapies in Clinical Practice
September 22, 2016
Laura Tolbaños-roche, María Teresa Miró Barrachina, Ignacio Ibáñez Fernández
Objective: To analyze the effect of the 'Exercise Without Movement' (E.W.M) yoga method on mindfulness and on the improvement of anxiety and depression symptoms. Methods: A quasi-experimental study examined the effect of one month E.W.M. intervention among 38 participants who were enrolled voluntarily to both groups, study (n = 16) and control (n = 22). Five participants dropped out during the...
Translational Psychiatry
September 20, 2016
Daniel M. Rotroff, Daniel Corum, Alison A. Motsinger‐Reif et al.
99 citations
Ketamine, at sub-anesthetic doses, is reported to rapidly decrease depression symptoms in patients with treatment-resistant major depressive disorder (MDD). Many patients do not respond to currently available antidepressants, (for example, serotonin reuptake inhibitors), making ketamine and its enantiomer, esketamine, potentially attractive options for treatment-resistant MDD. Although...